|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C12P 21/08 | (2006.01) | ||
| A61K 9/08 | (2006.01) |
| (11) | Patento numeris | 3351269 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17205734.1 |
| Europos patento paraiškos padavimo data | 2006-06-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 690582 P | 2005-06-14 | US |
| (72) |
GOKARN, Yatin, R., US
KRAS, Eva, US
BREMS, David, N., US
REMMELE, Richard, Louis, Jr., US
HERSHENSON, Susan, Irene, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive M/S 28-2-C, Thousand Oaks, CA 91320-1799,
US
|
| (54) | SELF-BUFFERING PROTEIN FORMULATIONS |
| SELF-BUFFERING PROTEIN FORMULATIONS |